N/A
N=230
Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
HIV
Bottom Line
View on ClinicalTrials.gov: NCT01161446 ↗Enrolled (actual)
230
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: HIV Testing Frequency — 5.3; 3.6 HIV tests — p=<0.0001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test (Behavioral); Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- University of Washington
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HIV Testing Frequency |
5.3; 3.6 | <0.0001 sig |
| SECONDARY Condomless Anal Intercourse With HIV-positive or Unknown Status Partner in Last 3 Months |
16; 17; 26; 23 | — |
| SECONDARY Bacterial Sexually Transmitted Infections |
5; 11 | — |
| SECONDARY Number of Male Condomless Anal Intercourse Partners in Last 3 Months |
1.375; 2.050; 2.337; 2.141 | — |
Summary
The purpose of this study is to determine whether the availability of home self-testing for HIV will increase HIV testing frequency among men who have sex with men without negatively impacting their risk for HIV acquisition.
Eligibility Criteria
Inclusion Criteria
- Male
- Age ≥18
- Has sex with men
- HIV-negative
- Meets PHSKC HIV/STD Program definition of "high risk"
- Plans to live in Seattle for the next 15 months
Exclusion Criteria
- Unable to safely and confidentially receive or store a home testing kit
Data sourced from ClinicalTrials.gov (NCT01161446). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.